The Oncology Institute Inc (NAS:TOI)
$ 0.4337 0.026 (6.27%) Market Cap: 32.28 Mil Enterprise Value: 86.29 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 28/100

Q4 2021 Oncology Institute Inc Earnings Call Transcript

Mar 10, 2022 / 10:00PM GMT
Release Date Price: $4.93 (-14.56%)
Operator

Good afternoon, and welcome to the Oncology Institute's fourth-quarter and full-year 2021 earnings conference call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A. At this time, I would like to turn the conference over to Scott Dalgleish, Chief Financial Officer at the Oncology Institute. Thank you. You may begin your presentation.

Scott Dalgleish
The Oncology Institute, Inc - CFO

Good afternoon, everyone, and thanks for joining us to discuss TOI's fourth-quarter and full-year 2021 results. Before we begin, we would like to remind you that this conference call will include forward-looking statements. These statements include our future expectations regarding financial results and guidance, market opportunities, and our growth. These statements, which are subject to various risks, uncertainties, and assumptions, could cause our actual results to differ materially from these statements. These risks, uncertainties, and assumptions are detailed in this afternoon's press release as well as our filings with the SEC,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot